Loading...

Nika BioTechnology, Inc.

NIKA•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.75
$0.00(0.00%)
U.S. Market opens in 14h 20m

Nika BioTechnology, Inc. (NIKA) Stock Overview

Explore Nika BioTechnology, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap785M
P/E Ratio-10275.58
EPS (TTM)N/A
ROE0.29%
Fundamental Analysis

AI Price Forecasts

1 Month$0.65
3 Months$0.37
1 Year Target$0.00

NIKA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nika BioTechnology, Inc. (NIKA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.66, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -10275.58 and a market capitalization of 785M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-0.81%
3-Month Change
97.21%
6-Month Change
56.48%
Year-to-Date (YTD) Change
97.16%
1-Year Change
-25.06%
3-Year Change
274.70%
5-Year Change
274.70%
All-Time (Max) Change
274.70%

Contact Information

https://www.nikapharmaceuticals.com
702 326 3615
2269 Merrimack Valley Avenue, Henderson, NV, 89044

Company Facts

IPO DateMar 14, 2024
CountryUS
Actively Trading

Frequently Asked Questions